Hello,
We wanted to make sure you saw our action alert about an exciting public comment opportunity! The Interagency Autism Coordinating Committee (IACC) is looking for comments on research priorities related to conditions that commonly co-occur with autism. Comments are due by February 14th. Learn more in the message below. Thank you for taking action on this important research opportunity!
---------- Forwarded message ----------
From: Autistic Self Advocacy Network <
[email protected]>
Date: Wed, January 24, 2024
Subject: Share your thoughts on autism research with the IACC!
Submitting public comments is an important way for self-advocates to make our needs and priorities known when it comes to public policy. This month, there is an important opportunity to make your thoughts on autism research heard!
Before February 14, 2024 submit your public comments [[link removed]] to the Interagency Autism Coordinating Committee (IACC) about autism research. This round of comments is specifically about priorities related to physical and mental health conditions that commonly co-occur with autism. You could share your thoughts about what kind of research is needed on conditions that commonly co-occur with autism, like Ehlers-Danlos Syndrome (EDS), depression, ADHD, and many more. Your comments will help the IACC know which research topics are most important to the autistic community!
The IACC makes recommendations about where federal funds for autism research should go and what subjects should be prioritized. The IACC meets several times each year to discuss where these funds should go and how much money different research subjects should get. Research priorities should reflect what the autistic community needs [[link removed]] — and before each IACC meeting, we have the opportunity to tell the government what research should be prioritized, and where the gaps in funding are.
The IACC’s next meeting is January 24, 2024. Public comments [[link removed]] are open until February 14, 2024.
Autistic Self Advocacy Network
PO Box 66122
Washington, DC 20035
United States
If you believe you received this message in error or wish to no longer receive email from us, please unsubscribe: [link removed] .